James Huang, Director at ZIOPHARM ONCOLOGY INC (ZIOP), bought 100,000 shares at $1.71 ($171K) on 2021-09-01, disclosed to the SEC on 2021-09-03.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| ATRA | SELL | 2026-01-14 | $489K | — | Filing → |
| ATRA | BUY | 2025-07-21 | $373K | — | Filing → |
| CASI | BUY | 2022-09-08 | $304K | — | Filing → |